Select a community
All Communities
Home > Rebif Treatment Evaluations

One of 58 patient evaluations for Interferon beta-1a SubQ injection

  • icetta
    Sex: M
    Data Quality: 3 stars
    MS: 3 yrs
    Relapsing-Remitting
    Sensation: Mild
    Overall: None
    Cognition: mild
    Vision: mild
    Speech: mild
    Swallowing: none
    Upper limb: none
    Walking: mild
    See profile
  • by icetta
    current dosage:
    44 mcg/0.5 mL 3 times a week
    time on dosage:
    about 2 years
    purpose:
    Multiple Sclerosis (MS)
  • 82c67c11a5a444e69fe0c08751d1282a9b610752
Multiple Sclerosis (MS) Efficacy Side Effects Adherence Burden Specific Side Effects
Oct 11, 2009 Can't tell None Always A little
  • Icon_thumb_off 0 helpful marks